Suven Life Sciences : June 03, 2023Suven announces two poster presentations from the phase-2 (PoC) study on samelisant (SUVN-G3031)
Suven Life Sciences announces two poster presentations including patient baseline characteristics and demographics from the phase-2 Proof of Concept study on samelisant at... | June 3, 2023
United States Research Society American Academy Of Sleep Medicine Suven Life Sciences Our Company About Sleep
Source: marketscreener.com